Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-03 4:12 pm Purchase | 2024-09-26 | 13G | Theriva Biologics, Inc. TOVX | Mitchell P. Kopin | 118,526 4.990% | 118,526 (New Position) | Filing History |
| 2024-10-02 10:53 am Purchase | 2024-09-27 | 13G | Theriva Biologics, Inc. TOVX | CVI Investments, Inc. | 232,237 9.900% | 232,237 (New Position) | Filing History |
| 2022-02-23 4:42 pm Sale | 2021-12-31 | 13G | Synthetic Biologics, Inc. SYN | Iroquois Capital Management LLC | 230,870 1.920% | -30,000 (-11.50%) | Filing History |
| 2022-02-10 6:11 pm Sale | 2021-12-31 | 13G | Synthetic Biologics, Inc. SYN | RENAISSANCE TECHNOLOGIES LLC | 2,060 0.020% | -121,713 (-98.34%) | Filing History |
| 2022-02-04 4:23 pm Purchase | 2021-12-31 | 13G | Synthetic Biologics, Inc. SYN | Hudson Bay Capital Management LP | 260,870 1.940% | 38,968 (+17.56%) | Filing History |
| 2021-03-02 3:33 pm Purchase | 2021-02-18 | 13D | Synthetic Biologics, Inc. SYN | Custodian Ventures LLC. | 222,450 2.100% | 26,000 (+13.23%) | Filing History |
| 2021-02-22 09:45 am Unchanged | 2020-12-31 | 13G | Synthetic Biologics, Inc. SYN | Iroquois Capital Management LLC | 260,870 9.990% | 0 (Unchanged) | Filing History |
| 2021-02-10 5:48 pm Purchase | 2020-12-31 | 13G | Synthetic Biologics, Inc. SYN | Hudson Bay Capital Management LP | 221,902 9.990% | 72,246 (+48.28%) | Filing History |
| 2021-02-10 12:23 pm Purchase | 2020-06-26 | 13G | Synthetic Biologics, Inc. SYN | RENAISSANCE TECHNOLOGIES LLC | 123,773 6.190% | 123,773 (New Position) | Filing History |
| 2021-01-06 11:16 am Purchase | 2020-12-29 | 13D | Synthetic Biologics, Inc. SYN | Custodian Ventures LLC. | 196,450 9.900% | 196,450 (New Position) | Filing History |
| 2020-02-14 10:36 am Unchanged | 2019-12-31 | 13G | Synthetic Biologics, Inc. SYN | Iroquois Capital Management LLC | 260,870 9.990% | 0 (Unchanged) | Filing History |